title: Recent developments with the New Zealand regulated market approach to 'low-risk' psychoactive products.
authors.affiliation: SHORE and Whariki Research Centre, College of Health, Massey University, New Zealand.
authors.forename: Chris
authors.initials: C
authors.lastname: Wilkins
authors.affiliation: SHORE and Whariki Research Centre, College of Health, Massey University, New Zealand.
authors.forename: Marta
authors.initials: M
authors.lastname: Rychert
mesh_terms: D007880:Legislation, Drug; D009520:New Zealand; D011619:Psychotropic Drugs; D012306:Risk
chemical_list: D011619:Psychotropic Drugs
keywords: Animal testing; New Zealand Psychoactive Substances Act; Regulated drug markets; blanket ban; ‘failed’ pharmaceutical